NaxSwab OTC novel naloxone nasal swab successfully administered by children and adults to potentially rescue someone from an opioid overdose in study
BETHESDA, Md., April 13, 2023. Pocket Naloxone Corp., a startup pharmaceutical company with the vision of enhancing naloxone delivery, announced results from a human factors validation study, using the intend-to-market packaging and labeling,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 13, 2023 Category: Pharmaceuticals Source Type: clinical trials
Efficacy and Safety of Remo-Wax ® Oil (RWO) in Subjects With Isolated Itching of the External Ear Canal
Condition: Itching Intervention: Device: Remo-Wax® Oil Sponsor: Orion Corporation, Orion Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2023 Category: Research Source Type: clinical trials
Tranexamic Acid Does Not Appear to Prevent Maternal Hemorrhage After Cesarean Delivery
April 13, 2023 -- Tranexamic acid appears no more effective than placebo in reducing the need for blood transfusion or preventing maternal death in patients with increased risk for excessive bleeding because of cesarean delivery, according to a... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 13, 2023 Category: Pharmaceuticals Source Type: clinical trials
ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer
SOUTH SAN FRANCISCO, Calif., and VANCOUVER, Canada, April 12, 2023. ESSA Pharma Inc. ( " ESSA " , or the " Company " ), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 12, 2023 Category: Pharmaceuticals Source Type: clinical trials
ACELYRIN, INC. Announces Magnitude of Clinical Responses with Izokibep in Psoriatic Arthritis Continues to Improve with Longer Duration of Therapy
LOS ANGELES, April 11, 2023. ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced long-term 46-week data from a global Phase 2 trial... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 11, 2023 Category: Pharmaceuticals Source Type: clinical trials
Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds
April 11, 2023 -- A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 11, 2023 Category: Pharmaceuticals Source Type: clinical trials
CHOP-led Study Identifies Two Different Regulatory T Cell Populations
PHILADELPHIA, April 7, 2023. A regulatory class of human T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity, according to a new study led by Children ' s Hospital of Philadelphia... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 8, 2023 Category: Pharmaceuticals Source Type: clinical trials
